Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,951,208 papers from all fields of science
Search
Sign In
Create Free Account
5-vinyluracil
Known as:
5-ethenyl-2,4(1H,3H)-pyrimidinedione
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Uracil
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Nucleic Acids Research
P. Barr
Nucleic Acids Research
2016
Corpus ID: 43771776
The promoter of the gene for the major outer membrane llpoprotein, the most abundant protein in Escherichia coll. is considered…
Expand
2014
2014
Polymerase Synthesis of DNAs Bearing Vinyl Groups in the Major Groove and their Cleavage by Restriction Endonucleases
M. Mačková
,
R. Pohl
,
Michal Hocek
ChemBioChem
2014
Corpus ID: 205558805
DNA molecules containing 5‐vinyluracil, 5‐vinylcytosine, or 7‐deaza‐7‐vinyladenine were prepared by polymerase incorporation of…
Expand
2004
2004
Single Ascending Dose Tolerability, Pharmacokinetic–Pharmacodynamic Study of Dihydropyrimidine Dehydrogenase Inhibitor Ro 09-4889
S. Bellibas
,
I. Patel
,
+7 authors
G. Milano
Clinical Cancer Research
2004
Corpus ID: 16740572
Purpose: Ro 09-4889 was designed to enhance the anticancer efficacy of capecitabine (Xeloda) by generating a dihydropyrimidine…
Expand
2003
2003
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
K. Hattori
,
Y. Kohchi
,
+11 authors
N. Shimma
Bioorganic & Medicinal Chemistry Letters
2003
Corpus ID: 25929949
2003
2003
Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889
M. Endo
,
M. Miwa
,
+8 authors
H. Ishitsuka
International Journal of Cancer
2003
Corpus ID: 25367316
Capecitabine is an orally available fluoropyrimidine and is finally converted to 5‐FU selectively in tumor tissues. In our study…
Expand
1980
1980
Incorporation of 5-substituted uracil derivatives into nucleic acids. The isolation and gamma-radiation-sensitivity of bacteriophage T3 containing the thymine analogue 5-vinyluracil.
E. Chelton
,
M. Duggan
,
+4 authors
R. Walker
Biochemical Journal
1980
Corpus ID: 38788171
Bacteriophage T3 was produced in a form that contained 32% of its normal DNA thymine residues replaced with 5-vinyluracil…
Expand
1979
1979
The sensitivity of Mycoplasma mycoides var. capri cells to gamma-radiation after growth in a medium containing the thymine analogue 5-vinyluracil.
E T Chelton
,
A. S. Jones
,
R. Walker
Biochemical Journal
1979
Corpus ID: 31737409
Cells of the bacterium Mycoplasma mycoides var. capri grown in a medium containing the potential radiation-sensitive thymine…
Expand
1974
1974
A method for the rapid preparation of 5-vinyluracil in high yield.
A. S. Jones
,
G. P. Stephenson
,
R. Walker
Nucleic Acids Research
1974
Corpus ID: 22543558
A method for the rapid preparation of the thymineanalogue, 5-vinyluracil, in 83% yield from 5-(1-hydroxyethyl)uracil via the…
Expand
1973
1973
The chemistry of some 5-(2-hydroxyalkyl)uracil derivatives and a synthesis of 5-vinyluracil.
J. Fissekis
,
F. Sweet
Journal of Organic Chemistry
1973
Corpus ID: 29056850
1973
1973
Incorporation of 5-substituted uracil derivatives into nucleic acids. II. Incorporation of 5-vinyluracil into the DNA of Escherichia coli.
E. Chelton
,
C. Evans
,
A. S. Jones
,
R. Walker
Biochimica et Biophysica Acta
1973
Corpus ID: 40608406
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE